Carregant...
A Baseline Analysis of Regulatory Review Timelines for ANVISA: 2013–2016
BACKGROUND: The Brazilian health regulatory agency (Agência Nacional de Vigilância Sanitária, ANVISA) has embarked on transformational initiatives to fulfill its mandate to provide timely access to safe, effective, and quality therapeutics. A new Brazilian law was enacted to provide the agency with...
Guardat en:
| Publicat a: | Ther Innov Regul Sci |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7704494/ https://ncbi.nlm.nih.gov/pubmed/32519282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s43441-020-00169-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|